NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer Gene Therapy



Researchers from Massachusetts Institute of Technology, Department of Chemical Engineering describe findings in cancer gene therapy



April 15th, 2008

Current study results from the report, 'Tumor-targeted gene delivery using molecularly engineered hybrid polymers functionalized with a tumor-homing peptide,' have been published. "Before gene therapy can be used in clinical settings, safe and efficient DNA delivery systems must be developed to overcome a range of extra-and intracellular transport barriers. As a step toward the development of a modular, multifunctional gene delivery system to overcome these diverse barriers, we have developed a family of linear-dendritic 'hybrid' polymers which contain functionalities for tissue targeting, minimization of nonspecific interactions, endosomal buffering, and DNA binding," scientists writing...


Source: Cancer Weekly (2008-04-15)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login